Neil Shen Holdings 13F: Latest HongShan (Sequoia China) Portfolio Changes
HongShan (Sequoia China). Top VC in China, Sequoia legacy. Neil Shen is consistently ranked as one of the world's best venture capitalists. He is famous for early investments in Alibaba, ByteDance, and Meituan, shaping the modern Chinese internet landscape.
As of the latest Q2 2026 13F filing, Neil Shen (managing HongShan (Sequoia China)) reported a public portfolio value of $1.2B with 20 positions. This page tracks latest holdings, latest 13F changes, top buys, top sells, and top holdings from the public filing. The top recent buy was GYRE. The top recent sell was BULLW.
Open interactive portfolioLatest 13F portfolio changes
Neil Shen holdings 13F summary: the latest HongShan (Sequoia China) portfolio changes show top holdings including PDD, FUTU HLDGS, PONY AI, CIRCLE INTERNET GROUP, and KE HLDGS, reported top buys such as GYRE THERAPEUTICS and YIMUTIAN, and top sells or reductions such as WEBULL and YIMUTIAN.
Latest filing metadata: quarter Q2 2026; report date 2026-06-30; filing date 2026-08-13; disclosure source SEC 13F.
Neil Shen 13F portfolio and latest holdings overview
Neil Shen's Q2 2026 13F holdings show HongShan (Sequoia China) reporting 20 positions with a disclosed portfolio value of $1.2B. For readers searching Neil Shen 13F holdings, Neil Shen portfolio, HongShan (Sequoia China) holdings, or latest 13F changes, the latest top holdings include PDD, FUTU HLDGS, PONY AI, CIRCLE INTERNET GROUP, and KE HLDGS.
The three largest reported positions add up to roughly 82.5%, which helps readers judge portfolio concentration rather than just headline AUM. The largest reported sector exposure is Consumer Discretionary at 72.3% of the disclosed portfolio. This makes the page useful for comparing the manager's actual disclosed exposure with market narratives around the same names.
The latest change data highlights reported buys such as GYRE THERAPEUTICS and YIMUTIAN and reported reductions or exits such as WEBULL and YIMUTIAN. Those changes should be read as historical disclosure signals, not as real-time trade alerts.
The filing metadata lists report date 2026-06-30, filing date 2026-08-13, SEC accession 0001193125-26-348168. SEC 13F reports are normally published up to 45 days after quarter end, so the data is best used to understand institutional positioning after the fact rather than to infer today's exact portfolio.
Neil Shen portfolio analytics
the top five positions account for 88.3% of disclosed value; the largest sector exposure is Consumer Discretionary at 72.3%; reported buy and sell activity implies roughly 6.7% turnover this period; cost-basis P&L across 20 tracked positions averages -31.3% (5/14 currently in profit).
Top reported holdings
| Holding | Reported value | Weight | Quarter change |
|---|---|---|---|
| PDD whale holders PDD HOLDINGS INC | $865.7M | 72.3% | Held |
| FUTU whale holders FUTU HLDGS LTD | $69.4M | 5.8% | Held |
| PYAIF whale holders PONY AI INC | $52.4M | 4.4% | Held |
| CRCL whale holders CIRCLE INTERNET GROUP INC | $41.9M | 3.5% | Held |
| BEKE whale holders KE HLDGS INC | $28.2M | 2.4% | Held |
| GYRE whale holders GYRE THERAPEUTICS INC | $24.7M | 2.1% | New |
| BZ whale holders KANZHUN LIMITED | $24.5M | 2.0% | Held |
| AVBP whale holders ARRIVENT BIOPHARMA INC | $23.0M | 1.9% | Held |
| DDL whale holders DINGDONG CAYMAN LTD | $19.5M | 1.6% | Held |
| GPCR whale holders STRUCTURE THERAPEUTICS INC | $14.3M | 1.2% | Held |
Top buys
- GYRE whale holders — GYRE THERAPEUTICS INC ($24.7M)
- YMT whale holders — YIMUTIAN INC ($121.6K)
Top sells
- BULLW whale holders — WEBULL CORP ($55.2M)
- YMT whale holders — YIMUTIAN INC ($543.8K)
Allocation
- Consumer Discretionary: 72.3%
- Other: 18.1%
- Health Care: 5.2%
- Communication Services: 3.5%
- Information Technology: 0.9%
Data notes
Report date: 2026-06-30
Disclosure source: SEC 13F
SEC 13F filings are delayed public disclosures and do not include every asset class, short positions, or real-time trades.
Related investor portfolios
- Dodge & Cox 13F holdings and portfolio changes — Dodge & Cox
- John Paulson 13F holdings and Paulson & Co portfolio changes — Paulson & Co
- Edgewood Management 13F holdings and Edgewood Management LLC portfolio changes — Edgewood Management LLC
- Lee Ainslie 13F holdings and Maverick Capital portfolio changes — Maverick Capital
- Bill Miller 13F holdings and Miller Value Partners portfolio changes — Miller Value Partners
- Samuel Isaly 13F holdings and OrbiMed Advisors portfolio changes — OrbiMed Advisors
- NPS Korea 13F holdings and National Pension Service portfolio changes — National Pension Service
- Dorsey Asset Management 13F holdings and portfolio changes — Dorsey Asset Management
Learn more in Whale Analyzer Academy
Learn more in Whale Analyzer Academy:
Frequently asked questions
Neil Shen 13F Holdings
The Q2 2026 13F profile for Neil Shen and HongShan (Sequoia China) shows 20 reported positions, $1.2B in disclosed portfolio value, and top holdings including PDD, FUTU HLDGS, PONY AI, CIRCLE INTERNET GROUP, and KE HLDGS.
What is Neil Shen buying? Latest 13F changes
The latest tracked change data for Neil Shen highlights reported buys such as GYRE THERAPEUTICS and YIMUTIAN and reported sells or reductions such as WEBULL and YIMUTIAN.
HongShan (Sequoia China) top holdings
HongShan (Sequoia China) top holdings are summarized from public disclosures with reported values, weights, portfolio concentration, top buys, top sells, and filing metadata where available.
Neil Shen buys and sells
Use the top buys and top sells sections above to compare Neil Shen's reported additions, reductions, exits, and latest portfolio activity against other tracked investors.
How delayed is Neil Shen's 13F data?
SEC Form 13F requires institutional investment managers with $100M+ in US equities to disclose their holdings quarterly. Read our comprehensive 13F guide for timing, coverage, and limitations. Read the Whale Analyzer 13F guide.